Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03287817
Title CD19/22 CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma (ALEXANDER)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Autolus Limited
Indications

primary mediastinal B-cell lymphoma

B-cell lymphoma

diffuse large B-cell lymphoma

Therapies

Pembrolizumab

Cyclophosphamide + Fludarabine

CD19/CD22 CAR T cells

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.